Executive Profile*

Richard T. Dean Ph.D.

AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 1 different industries.

See Board Relationships


Dr. Richard T. Dean is the Chief Executive Officer and President at Xanthus Pharmaceuticals Inc. He found the company to develop novel oncology drugs in 2004. Dr. Dean serves as an Investment Advisor of NeoMed Fund, Oslo, Norway and served as the Head of Strategic Business Development, Diagnostic and Radiopharmaceuticals, Schering AG, Berlin, Germany. He was a Vice President at its Berlex subsidiary and the President at Diatide Research Laboratories. Dr. Dean also has ...

Read Full Background

Corporate Headquarters*

Nine Delta Drive
Londonderry, New Hampshire 03053

United States

Phone: 603-437-8970
Fax: --

Board Members Memberships*



Cornell University
University of Michigan
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.